Trane CEO Regnery exercises options, sells 43,778 shares
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Trane Technologies plc reported that Chair and CEO David S. Regnery exercised 43,778 stock options at an exercise price of $70.22 per share, receiving the same number of ordinary shares, and on the same date sold 43,778 ordinary shares at $475.00 per share pursuant to a Rule 10b5-1 trading plan adopted on May 4, 2026. A revocable trust established by his spouse held 24,500 ordinary shares after these transactions.
Insider Trade Summary 10b5-1
Exercise and Sale: 43,778 shares ($17.72M approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Regnery David S
Role
Chair and CEO
Sold
43,778 shs ($20.79M)
Approx. gross sale proceeds
$20.79M
Approx. exercise cost
$3.07M
Approx. pre-tax spread
$17.72M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3 | 43,778 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 43,778 | $70.22 | $3.07M |
| Sale | Ordinary Shares F1 | 43,778 | $475.00 | $20.79M |
| Holding | Ordinary Shares (Trust) F2 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Ordinary Shares — 96,950.331 shares (Direct);
Ordinary Shares (Trust) — 24,500 shares (Indirect, By Revocable Trust)
Footnotes (3)
- F1. Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 4, 2026.
- F2. Shares held by a revocable trust established by the reporting person's spouse, of which trust the reporting person's spouse is the sole trustee and sole beneficiary.
- F3. The stock option vested in three (3) pro rata annual installments beginning on February 6, 2019.
Key Figures
Options exercised: 43,778 shares
Exercise price: $70.22 per share
Shares sold: 43,778 shares
+5 more
8 metrics
Options exercised
43,778 shares
Stock options exercised on August 5, 2026
Exercise price
$70.22 per share
Conversion or exercise price of stock options exercised
Shares sold
43,778 shares
Ordinary shares sold on August 5, 2026
Sale price
$475.00 per share
Price for sale of ordinary shares on August 5, 2026
Indirect trust holdings
24,500 shares
Ordinary shares held by spouse’s revocable trust after transactions
Option expiration
February 5, 2028
Expiration date of the exercised stock option grant
Option vesting schedule
Three annual installments
Option vested in three pro rata annual installments beginning February 6, 2019
Rule 10b5-1 plan adoption date
May 4, 2026
Adoption date of the Rule 10b5-1 plan governing the share sale
Key Terms
Rule 10b5-1 Plan, Stock Option (Right to Buy), revocable trust, Ordinary Shares
4 terms
Rule 10b5-1 Plan regulatory
"Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with an exercise price of $70.22"
revocable trust financial
"Shares held by a revocable trust established by the reporting person's spouse"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Trane Technologies (TT) CEO David Regnery report?
David Regnery reported exercising 43,778 stock options at $70.22 per share and selling 43,778 ordinary shares at $475.00 per share. The sale was executed under a Rule 10b5-1 trading plan adopted on May 4, 2026, with additional shares held via a spouse’s trust.
What stock options did David Regnery exercise in Trane Technologies (TT)?
He exercised 43,778 stock options with a conversion or exercise price of $70.22 per share. The option vested in three pro rata annual installments beginning on February 6, 2019 and had an expiration date of February 5, 2028 before exercise.
What is the relationship of the trust holdings to David Regnery at Trane Technologies (TT)?
The indirectly held 24,500 ordinary shares are in a revocable trust established by his spouse. The filing notes that his spouse is the sole trustee and sole beneficiary of the trust, and these shares are reported as held indirectly by the reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.
